Sina Bavari

Corporate Officer/Principal at TONIX PHARMACEUTICALS HOLDING CORP.

Consumer Services

Health Technology

Profile

Sina Bavari is the founder of Healion Bio, Inc. He currently works as the EVP-Infectious Disease Research & Development at Tonix Pharmaceuticals Holding Corp.
Previously, he worked as the Chief Scientific Officer at the U.S.
Army Medical Research Institute for Infectious Diseases.
Bavari holds a graduate degree from the University of Southern California and a doctorate from the University of Nebraska Medical Center.

Sina Bavari active positions

Companies	Position	Start
TONIX PHARMACEUTICALS HOLDING CORP.	Corporate Officer/Principal	25/07/2022
Healion Bio, Inc. Healion Bio, Inc. BiotechnologyHealth Technology Part of Tonix Pharmaceuticals Holding Corp., Healion Bio, Inc. is a biotechnology development company based in Frederick, MD. The company is focused on developing the next generation of antiviral compounds, with two antiviral platforms: the HB-100 series of protease inhibitors and the HB-200/300 series of next-generation antiviral biologics. The HB-100 series is a first-in-class antiviral with an orthogonal mechanism of action to existing drugs. The company was founded by Sina Bavari and Simon Newman, with Simon Newman serving as CEO since incorporation. Healion Bio was acquired by Tonix Pharmaceuticals Holding Corp. on February 01, 2023 for $1.20 million.	Founder	-

All active positions of Sina Bavari

Former positions of Sina Bavari

Companies	Position	End
U.S. Army Medical Research Institute for Infectious Diseases	Chief Tech/Sci/R&D Officer	-

See the detail of Sina Bavari's experience

Training of Sina Bavari

University of Southern California	Graduate Degree
University of Nebraska Medical Center	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sina Bavari's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TONIX PHARMACEUTICALS HOLDING CORP.	Health Technology

Private companies	1
Healion Bio, Inc. Healion Bio, Inc. BiotechnologyHealth Technology Part of Tonix Pharmaceuticals Holding Corp., Healion Bio, Inc. is a biotechnology development company based in Frederick, MD. The company is focused on developing the next generation of antiviral compounds, with two antiviral platforms: the HB-100 series of protease inhibitors and the HB-200/300 series of next-generation antiviral biologics. The HB-100 series is a first-in-class antiviral with an orthogonal mechanism of action to existing drugs. The company was founded by Sina Bavari and Simon Newman, with Simon Newman serving as CEO since incorporation. Healion Bio was acquired by Tonix Pharmaceuticals Holding Corp. on February 01, 2023 for $1.20 million.	Health Technology